Kamada Ltd (KMDA) stock
KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.07−0.09 (-1.10%)
Close on Nov 18, 2026Market cap $465.53MP/E –Yield –
Kamada revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Kamada's revenue for the twelve months ending Jun 30, 2026 was $191.85M, up 13.2% year over year. For fiscal 2025 it was $180.46M, up 12.1% from the year before. Over ten years it grew 9.9% a year on average. The highest annual figure on record is $180.46M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $180.46M | +12.1% |
| FY2024 | Dec 31, 2024 | $160.95M | +12.9% |
| FY2023 | Dec 31, 2023 | $142.52M | +10.2% |
| FY2022 | Dec 31, 2022 | $129.34M | +24.8% |
| FY2021 | Dec 31, 2021 | $103.64M | -22.2% |
| FY2020 | Dec 31, 2020 | $133.25M | +4.8% |
| FY2019 | Dec 31, 2019 | $127.19M | +11.1% |
| FY2018 | Dec 31, 2018 | $114.47M | +11.3% |
| FY2017 | Dec 31, 2017 | $102.83M | +32.7% |
| FY2016 | Dec 31, 2016 | $77.49M | +10.9% |
| FY2015 | Dec 31, 2015 | $69.91M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $54.92M | +22.7% |
| Q1 FY2026 | Mar 31, 2026 | $45.24M | +2.8% |
| Q4 FY2025 | Dec 31, 2025 | $44.68M | +14.5% |
| Q3 FY2025 | Sep 30, 2025 | $47.01M | +12.6% |
| Q2 FY2025 | Jun 30, 2025 | $44.75M | +5.4% |
| Q1 FY2025 | Mar 31, 2025 | $44.02M | +16.6% |
| Q4 FY2024 | Dec 31, 2024 | $39.01M | +7.1% |
| Q3 FY2024 | Sep 30, 2024 | $41.74M | +10.0% |
| Q2 FY2024 | Jun 30, 2024 | $42.47M | +13.4% |
| Q1 FY2024 | Mar 31, 2024 | $37.74M | +122778.5% |
| Q4 FY2023 | Dec 31, 2023 | $36.43M | -71.8% |
| Q3 FY2023 | Sep 30, 2023 | $37.93M | +117645.3% |
| Q2 FY2023 | Jun 30, 2023 | $37.44M | +58.7% |
| Q1 FY2023 | Mar 31, 2023 | $30.71K | -99.9% |
| Q4 FY2022 | Dec 31, 2022 | $129.26M | +310.7% |
| Q3 FY2022 | Sep 30, 2022 | $32.22K | -99.9% |
| Q2 FY2022 | Jun 30, 2022 | $23.59M | -2.7% |
| Q1 FY2022 | Mar 31, 2022 | $28.09M | -10.9% |
| Q4 FY2021 | Dec 31, 2021 | $31.47M | -10.9% |
| Q3 FY2021 | Sep 30, 2021 | $23.03M | – |
| Q2 FY2021 | Jun 30, 2021 | $24.24M | – |
| Q4 FY2020 | Dec 31, 2020 | $31.54M | – |
| Q3 FY2020 | Sep 30, 2020 | $35.33M | – |
See a number that looks wrong?